The Potential of Proteomics in Cardiovascular Risk Prediction
Proteogenomics & Translational Omics Stage
Day 2
Cancer DiagnosticsMulti-Omics
Information
- Risk prediction is a core component in primary prevention in cardiovascular diseases
- The usefulness of these tools depend on how accurate the predictions are and researchers constantly look at better biomarkers to improve prediction performance
- High-throughout proteomic assays provides a potential transformative prediction accuracy
- As few as 86 proteins could provide a strong improvement over the current state-of-the-art clinical risk prediction models
